Similar Articles
951 CDH1 promoter polymorphism (-347G→GA) is a possible prognostic factor in sporadic colorectal cancer
952 Metabolic syndrome and risk of subsequent colorectal cancer
953 Expression of γ-synuclein in colorectal cancer tissues and its role on colorectal cancer cell line HCT116
954 UGT1A1 gene polymorphism: Impact on toxicity and efficacy of irinotecan-based regimens in metastatic colorectal cancer
955 Undefined familial colorectal cancer
956 Concept of chemoprevention in colorectal cancer
957 Telomere function in colorectal cancer
958 Sirolimus, bevacizumab, 5-Fluorouracil and irinotecan for advanced colorectal cancer: A pilot study
959 Secondary hepatic resection as a therapeutic goal in advanced colorectal cancer
960 Disparities in colorectal cancer in African-Americans vs Whites: Before and after diagnosis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA